Ocugen, Inc.
OCGN
$1.35
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.49M | 1.53M | -193.00K | 1.75M | 1.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.49M | 1.53M | -193.00K | 1.75M | 1.37M |
| Cost of Revenue | 10.69M | 11.26M | 10.67M | 11.15M | 8.40M |
| Gross Profit | -9.20M | -9.72M | -10.86M | -9.40M | -7.03M |
| SG&A Expenses | 7.24M | 8.12M | 6.13M | 8.23M | 6.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.93M | 19.37M | 16.80M | 19.38M | 15.17M |
| Operating Income | -16.44M | -17.84M | -17.00M | -17.63M | -13.80M |
| Income Before Tax | -24.88M | -19.18M | -17.71M | -20.05M | -14.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -24.88M | -19.18M | -17.71M | -20.05M | -14.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -24.88M | -19.18M | -17.71M | -20.05M | -14.74M |
| EBIT | -16.44M | -17.84M | -17.00M | -17.63M | -13.80M |
| EBITDA | -15.86M | -17.25M | -16.40M | -16.68M | -12.55M |
| EPS Basic | -0.07 | -0.06 | -0.06 | -0.07 | -0.05 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 |
| EPS Diluted | -0.07 | -0.06 | -0.06 | -0.07 | -0.05 |
| Normalized Diluted EPS | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 338.68M | 327.54M | 312.34M | 304.00M | 292.07M |
| Average Diluted Shares Outstanding | 338.68M | 327.54M | 312.34M | 304.00M | 292.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |